Get the Stockscreener App
67.01
0.84%
0.41
Dexcom Inc stock is traded at $67.01, with a volume of 1.65M.
It is up +0.84% in the last 24 hours and down -8.20% over the past month.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
See More
Previous Close:
$66.60
Open:
$67.22
24h Volume:
1.65M
Relative Volume:
0.34
Market Cap:
$25.80B
Revenue:
$4.66B
Net Income/Loss:
$836.30M
P/E Ratio:
32.02
EPS:
2.093
Net Cash Flow:
$1.08B
1W Performance:
-0.74%
1M Performance:
-8.20%
6M Performance:
-1.67%
1Y Performance:
-8.69%
1-Day Range:
$65.53
$68.09
1-Week Range:
$65.09
$68.76
52-Week Range:
$54.11
$89.98
Dexcom Inc Stock (DXCM) Company Profile
Name
Dexcom Inc
Sector
Industry
Phone
(858) 200-0200
Address
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Compare DXCM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
67.03 | 25.63B | 4.66B | 836.30M | 1.08B | 2.093 |
ABT
Abbott Laboratories
|
105.39 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.26 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.69 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.56 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.44 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-12-26 | Downgrade | Barclays | Equal Weight → Underweight |
| Dec-02-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-25-25 | Initiated | Evercore ISI | In-line |
| Oct-21-25 | Resumed | Stifel | Buy |
| Sep-08-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-21-25 | Initiated | Argus | Buy |
| Jun-16-25 | Initiated | Truist | Buy |
| May-30-25 | Initiated | Goldman | Buy |
| Apr-10-25 | Initiated | Mizuho | Outperform |
| Feb-03-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Jan-16-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jul-26-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-26-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-24 | Initiated | Redburn Atlantic | Neutral |
| Mar-12-24 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-17-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Jan-26-23 | Initiated | Wolfe Research | Outperform |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-15-22 | Initiated | Bernstein | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-07-22 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-18-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-28-21 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Jan-06-21 | Upgrade | UBS | Neutral → Buy |
| Oct-02-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| May-27-20 | Reiterated | Piper Sandler | Overweight |
| May-14-20 | Initiated | Wells Fargo | Equal Weight |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Nov-07-19 | Reiterated | Canaccord Genuity | Buy |
| Nov-07-19 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-23-19 | Initiated | Stifel | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Oct-19-18 | Upgrade | Goldman | Sell → Neutral |
| Sep-12-18 | Upgrade | Northland Capital | Under Perform → Market Perform |
| Aug-02-18 | Reiterated | Canaccord Genuity | Buy |
| Jul-02-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-08-18 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-18 | Initiated | BofA/Merrill | Buy |
| May-03-18 | Reiterated | Canaccord Genuity | Buy |
| Apr-04-18 | Initiated | Goldman | Sell |
| Apr-04-18 | Initiated | Guggenheim | Neutral |
| Mar-23-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-04-18 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-28-17 | Reiterated | Wedbush | Outperform |
View All
Dexcom Inc Stock (DXCM) Latest News
DexCom Inc (NASDAQ:DXCM) Presents a Growth Stock Breakout Opportunity - ChartMill
Nordea Investment Management AB Acquires 137,986 Shares of DexCom, Inc. $DXCM - MarketBeat
Assenagon Asset Management S.A. Increases Position in DexCom, Inc. $DXCM - MarketBeat
Dexcom Inc. stock rises on Evercore ISI upgrade to Outperform with $90 target amid CGM market moment - AD HOC NEWS
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
Dexcom Inc. stock faces spotlight amid continuous glucose monitoring sector evolution and governance - AD HOC NEWS
Bronstein, Gewirtz & Grossman, LLC Is Investigating DexCom, Inc. (DXCM) And Encourages Investors to Connect - ACCESS Newswire
DexCom (NASDAQ:DXCM) Upgraded to "Outperform" at Evercore - MarketBeat
DXCM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
E. Ohman J or Asset Management AB Has $7.67 Million Stock Position in DexCom, Inc. $DXCM - MarketBeat
DexCom Inc. stock underperforms Monday when compared to competitors - MarketWatch
DexCom, Inc. $DXCM Shares Acquired by Gradient Investments LLC - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages DexCom, Inc. (DXCM) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
DXCM Stock Price, Quote & Chart | DEXCOM INC (NASDAQ:DXCM) - ChartMill
Devon Energy Corp stock eyes dividend surge amid Coterra merger push and rising oil prices - ad-hoc-news.de
Union Bancaire Privee UBP SA Increases Stake in DexCom - National Today
Union Bancaire Privee UBP SA Has $1.41 Million Stake in DexCom, Inc. $DXCM - MarketBeat
Here's why you should hold DexCom stock in your portfolio for now - MSN
Mizuho raises DexCom (DXCM) price target to $90 from $78 after earnings beat - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against DexCom, Inc. (DXCM) And Encourages Stockholders to Reach Out - ACCESS Newswire
Dexcom stock falls despite Q4 earnings beat, G7 rollout drives growth - MSN
Insider Selling: DexCom (NASDAQ:DXCM) EVP Sells 1,700 Shares of Stock - MarketBeat
Dexcom (DXCM) legal chief sells 1,700 shares in 10b5-1 trade - Stock Titan
Mizuho Markets Cayman LP Acquires 53,093 Shares of DexCom, Inc. $DXCM - MarketBeat
CIBC Private Wealth Group LLC Acquires 2,294,709 Shares of DexCom, Inc. $DXCM - MarketBeat
Block Trades: Will DexCom Inc outperform the market in YEAR2026 Chart Watch & Verified Momentum Stock Watchlist - baoquankhu1.vn
DXCM Stock Falls Despite FDA Clearance for Dexcom Smart Basal - MSN
Bronstein, Gewirtz & Grossman, LLC Is Investigating DexCom, Inc. (DXCM) And Encourages Stockholders to Connect - ACCESS Newswire
DexCom, Inc. $DXCM Shares Purchased by Mizuho Markets Cayman LP - MarketBeat
Bank of Nova Scotia Trims Stake in DexCom - National Today
DexCom, Inc. $DXCM Shares Sold by Bank of Nova Scotia - MarketBeat
Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know - Yahoo Finance
[144] DEXCOM INC SEC Filing - Stock Titan
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now - Barchart
Is Dexcom (DXCM) Fairly Priced After Recent Share Price Pressure? - Yahoo Finance
Iron Triangle Partners LP Purchases New Shares in DexCom, Inc. $DXCM - MarketBeat
Holocene Advisors Invests $163.96M in DexCom - National Today
Holocene Advisors LP Makes New $163.96 Million Investment in DexCom, Inc. $DXCM - MarketBeat
Bamco Inc. NY Reduces Stock Position in DexCom, Inc. - National Today
DexCom, Inc. (DXCM) Showcases Next-Gen CGM Features at EASD 2025 - MSN
Cinctive Capital Management LP Takes $4.45 Million Position in DexCom, Inc. $DXCM - MarketBeat
Bamco Inc. NY Reduces Stock Position in DexCom, Inc. $DXCM - MarketBeat
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment - The Motley Fool
DexCom, Inc. (DXCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Aristotle Atlantic Partners LLC Makes New $13.01 Million Investment in DexCom, Inc. $DXCM - MarketBeat
Is DexCom (DXCM) Fairly Priced After Recent Share Price Pullback? - simplywall.st
Prosight Management LP Boosts DexCom Stake by 178.9% - National Today
Prosight Management LP Acquires 125,217 Shares of DexCom, Inc. $DXCM - MarketBeat
Thematics Asset Management Has $24.38 Million Stock Position in DexCom, Inc. $DXCM - MarketBeat
Ossiam Has $18.15 Million Stake in DexCom, Inc. $DXCM - MarketBeat
Wealth Advisors of Tampa Bay LLC Has $660,000 Holdings in DexCom, Inc. $DXCM - MarketBeat
Dexcom Inc Stock (DXCM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):